Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Taber

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 7, 2012
Disruptions in the supply of medications used in transplantation: implications and management strategies for the transplant clinicianJ C Krisl, C R Fortier, D J Taber
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 17, 2018
The effect of Share 35 on biliary complications: An interrupted time series analysisJ N Fleming, D J Taber, D Axelrod, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 20, 2015
A National Survey Assessing the Current Workforce of Transplant Pharmacists Across Accredited U.S. Solid Organ Transplant ProgramsD J Taber, N A Pilch, J Trofe-Clark, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 12, 2017
Mobile Health in Solid Organ Transplant: The Time Is NowJ N Fleming, D J Taber, J McElligott, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 26, 2001
Blue urticaria: a previously unreported adverse event associated with isosulfan blueT S Sadiq, W W Burns, D J Taber, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 10, 2013
Critical analysis of valganciclovir dosing and renal function on the development of cytomegalovirus infection in kidney transplantationM A Posadas Salas, D J Taber, E Chua, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2009
The use of drotrecogin alfa (activated) in solid organ transplant patients: a case seriesS Berkman, N A Weimert, D J Taber, et al.
Transplantation Proceedings|June 6, 2012
The impact of early corticosteroid withdrawal on graft survival in liver transplant recipientsH B Meadows, D J Taber, N A Pilch, et al.
Transplantation Proceedings|December 23, 2008
Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantationD J Taber, N A Weimert, F Henderson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2011
Evolution of the role of the transplant pharmacist on the multidisciplinary transplant teamR R Alloway, R Dupuis, S Gabardi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 7, 2012
Disruptions in the supply of medications used in transplantation: implications and management strategies for the transplant clinicianJ C Krisl, C R Fortier, D J Taber
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 17, 2018
The effect of Share 35 on biliary complications: An interrupted time series analysisJ N Fleming, D J Taber, D Axelrod, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 20, 2015
A National Survey Assessing the Current Workforce of Transplant Pharmacists Across Accredited U.S. Solid Organ Transplant ProgramsD J Taber, N A Pilch, J Trofe-Clark, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 12, 2017
Mobile Health in Solid Organ Transplant: The Time Is NowJ N Fleming, D J Taber, J McElligott, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 26, 2001
Blue urticaria: a previously unreported adverse event associated with isosulfan blueT S Sadiq, W W Burns, D J Taber, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 10, 2013
Critical analysis of valganciclovir dosing and renal function on the development of cytomegalovirus infection in kidney transplantationM A Posadas Salas, D J Taber, E Chua, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2009
The use of drotrecogin alfa (activated) in solid organ transplant patients: a case seriesS Berkman, N A Weimert, D J Taber, et al.
Transplantation Proceedings|June 6, 2012
The impact of early corticosteroid withdrawal on graft survival in liver transplant recipientsH B Meadows, D J Taber, N A Pilch, et al.
Transplantation Proceedings|December 23, 2008
Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantationD J Taber, N A Weimert, F Henderson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2011
Evolution of the role of the transplant pharmacist on the multidisciplinary transplant teamR R Alloway, R Dupuis, S Gabardi, et al.
Pageof 2